Paraffin section immunocytochemistry for estrogen receptor: The time has come
Open Access
- 15 June 1996
- Vol. 77 (12) , 2419-2422
- https://doi.org/10.1002/(sici)1097-0142(19960615)77:12<2419::aid-cncr1>3.0.co;2-h
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assaysCancer, 1996
- A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samplesHuman Pathology, 1995
- Biologic Significance of Quantitative Estrogen Receptor Immunohistochemical Assay by Image Analysis in Breast CancerAmerican Journal of Clinical Pathology, 1994
- Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniquesHuman Pathology, 1994
- Production of monoclonal antibodies to human estrogen‐receptor protein (ER) using recombinant ER (RER)International Journal of Cancer, 1993
- Production and Characterization of Monoclonal Antibodies Recognising Defined Regions of the Human Oestrogen ReceptorHybridoma, 1993
- Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine responseCancer, 1988
- Immunochemical Evaluation of Estrogen Receptor and Progesterone Receptor in Breast CancerPublished by Springer Nature ,1987
- IMPROVED SENSITIVITY: IN THE MEASUREMENT OF ESTROGEN RECEPTOR IN HUMAN BREAST CANCERJournal of Clinical Endocrinology & Metabolism, 1973
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896